Türkiye–U.S. M&A Daily Brief — September 1, 2026
Point72's HubX investment, TOGG discussions, Akfen's Bodrum Loft demerger, and major U.S.-led cross-border M&A developments.
As of 10:02 a.m. EDT / 3:02 p.m. Türkiye time on September 1, 2026. This daily brief covers developments from August 31 through September 1, together with a material Türkiye–U.S. technology investment not included in the prior update.
Point72 Private Investments makes a strategic investment in HubX
The leading direct Türkiye–U.S. transaction is Point72 Private Investments' investment in HubX, the İzmir- and Istanbul-origin consumer-technology company. The U.S. investor is providing an initial $50 million investment and has an option to invest up to a further $25 million. The transaction values HubX at a $1.2 billion pre-money valuation.
HubX states that it has grown without outside financing since its 2022 founding, has launched more than 40 mobile and web products, and reaches more than 600 million users in over 190 countries. The company says it will use the new capital not only for organic growth but also to acquire mobile and web products globally.
This is not a conventional control acquisition. It is a strategic minority or growth-equity investment, but it is one of the most significant recent transactions in the Türkiye–U.S. technology investment corridor. HubX's stated acquisition strategy may also position it as a future Turkish buyer in international technology M&A.
The central documents for review are the investment agreement and shareholders' agreement. Parties should assess Point72's board representation, reserved matters and veto rights, information rights, anti-dilution protection, liquidation preference, future-financing participation, and exit rights. Because the additional $25 million is optional, its exercise period, pricing mechanics, and performance conditions require careful review. It will also be important to determine whether HubX's future acquisitions require investor approval.
Source: HubX announcement on Point72's investment
Akfen GYO's Bodrum Loft partial demerger receives approval
Akfen Gayrimenkul Yatırım Ortaklığı A.Ş.'s extraordinary general meeting approved the partial demerger of the Bodrum Loft holiday-village operating right and related rights and obligations into Time-in Turizm Yatırımları A.Ş. The transferred net book value and the new company's capital are approximately TRY 1.094 billion. Akfen will hold 100% of Time-in.
In this facilitated partial-demerger structure, Akfen does not economically dispose of the asset. Instead, it places the Bodrum Loft business in a separate entity. The structure can make a later strategic-investor admission, joint venture, project financing, or outright sale more manageable: a buyer could acquire Time-in shares rather than the broader Akfen GYO platform.
After shareholder approval, registration and execution become the critical stage. The operating right, hotel permits, employees, customer and tour-operator agreements, brand and IP, advance payments, insurance, bank guarantees, and ongoing liabilities should be transferred completely. Contracts requiring third-party consent should not be overlooked on the assumption of universal succession.
TOGG share-transfer discussions are formally confirmed
Vestel Elektronik, AG Anadolu Grubu Holding, and Turkcell have confirmed through public disclosures that discussions are continuing regarding a potential transfer of a combined 46% interest in TOGG. Vestel and Anadolu each hold 23%. Turkcell and the Türkiye Wealth Fund are the potential acquirers. No binding share-purchase agreement, final decision, final ownership split, or transaction value has been announced.
The confirmations move the matter from market reporting to a potential M&A process acknowledged by the parties. A 46% block, however, does not by itself resolve control analysis. The allocation of shares between Turkcell and the Türkiye Wealth Fund, together with the governance rights of existing BMC and TOBB shareholders, will be decisive.
At a definitive agreement stage, board composition, reserved matters, capital calls, future financing, transfer and exit rights, government incentives, technology licences, and change-of-control clauses in supply agreements should be priority workstreams. Once the final ownership allocation is known, single-control and joint-control analysis under Turkish competition law should be revisited.
MİA Teknoloji–Lider Sistem: appraisal rights period begins
Shareholders meeting the applicable conditions and dissenting at MİA Teknoloji A.Ş.'s August 28 general meeting may exercise appraisal rights from September 1 through September 14 in connection with the merger by acquisition of Lider Sistem Teknolojileri A.Ş. The stated appraisal-rights price is TRY 38.48 per share. The exchange ratio is 2.9316, and MİA's post-merger capital is expected to be approximately TRY 986.51 million.
Appraisal-rights participation can affect the transaction's cash-leakage and financing profile. If usage is significant, the company may experience greater cash outflow than anticipated. The use level should be monitored against any maximum-cash condition or material financial threshold in the transaction documents or shareholder resolutions, and final share ownership and capitalization should be recalculated before registration.
Veritas Capital announces recommended Bodycote take-private
New York-based Veritas Capital has announced a recommended final offer for UK-listed Bodycote plc. The transaction has an equity value of about £1.65 billion and an enterprise value of approximately £1.85 billion, or $2.51 billion including debt. The total consideration is 940 pence per share, comprising 932.8 pence in cash and a 7.2 pence dividend retained by shareholders.
Veritas improved its price during competition with CVC and received unanimous board support. Bodycote operates a global network of approximately 135 facilities and is an important thermal-processing supplier to aerospace, defense, automotive, and industrial customers.
This is both the largest newly announced U.S.-led transaction in the period and a useful example of competitive-auction and interloper risk. Trading above the offer price can indicate that the market is pricing a possible higher proposal. Under the UK Takeover Code, the certainty of Veritas's offer, financing confirmation, a possible CVC counterbid, scheme or offer conditions, and break-fee restrictions should be monitored. UK national-security review, export controls, and sensitive-technology transfer also warrant review given the defense and aerospace customer base.
Source: Bodycote–Veritas transaction summary
Enovis submits binding offer for eCential Robotics
U.S.-based Enovis Corporation has submitted a binding offer for France-based eCential Robotics SAS, a surgical-robotics, orthopedic-navigation, and medtech company. The transaction contemplates approximately €155 million in upfront enterprise value, about €176 million of cash payable to shareholders at closing, and contingent consideration of up to €35 million. Closing is expected by year-end 2026 following the French works-council process and execution of a definitive acquisition agreement.
The transaction illustrates a key distinction in French M&A practice: a binding offer can precede the definitive agreement where employee information and consultation must occur first. Legal diligence should focus on the works-council process, French and EU merger-control requirements, patents and software IP, FDA clearances, third-party implant integration agreements, and product-liability files. The technical, regulatory, or commercial earnout milestones — and the acquirer's required efforts to achieve them — should be stated precisely.
Paramount Skydance–Warner Bros. Discovery: dispute over proposed bond
In the approximately $110 billion Paramount Skydance–Warner Bros. Discovery transaction, California, 11 other states, and the Writers Guild of America opposed Paramount's request for a $1.88 billion bond. Paramount argues that delay from antitrust litigation would trigger a ticking fee of about $7 million per day payable to Warner Bros. partners from October 1. California argues that those costs arise from Paramount's contractual choices and should not burden public antitrust plaintiffs.
The dispute is a reminder that a merger agreement's ticking fee is not merely a bilateral price-adjustment tool. In a contested transaction, it can become relevant to injunction-bond and damages-exposure arguments. Parties to large transactions should consider how the economic cost of regulatory delay is allocated and whether it could affect third-party litigation positions.
Key takeaway
Point72–HubX is the most material direct Türkiye–U.S. transaction in this brief. Beyond the initial $50 million investment and the $25 million option, HubX's intention to pursue global product and company acquisitions may have a longer-term impact on cross-border technology M&A. In Türkiye, the TOGG process, Akfen's subsidiary-model demerger, and the MİA–Lider appraisal-rights stage demonstrate three distinct corporate-transaction structures. In the U.S.-led cross-border market, Veritas–Bodycote and Enovis–eCential stand out for their competitive and procedural complexity.
This publication is for general informational purposes only and does not constitute legal advice. Transaction structures, regulatory requirements, and legal consequences depend on the specific parties, documents, jurisdictions, and facts involved.
Explore Topics
Written by
Muhammet Halil Ucar
ULF New York legal team — New York-based attorneys advising Turkish companies and investors on U.S. market entry, corporate law, real estate, and international trade.